Search research articles
Contact Us
Filters
Showing results (31-40 of 109) with videos related to
Page
of 11
Sort By:
Journal of the American College of Cardiology
|
October 19, 2004
The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease
Justin Ezekowitz, Finlay A McAlister, Karin H Humphries, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
April 12, 2024
Impact of the method of calculating 30-day readmission rate after hospitalization for heart failure. Data from the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry
Samaneh Salimian, Sean A Virani, Thomas M Roston, et al.
Frontiers in Cardiovascular Medicine
|
November 8, 2019
Screening and Initiating Supportive Care in Patients With Heart Failure
Quynh Nguyen, Kaiming Wang, Anish Nikhanj, et al.
Archives of Internal Medicine
|
April 14, 2004
The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes
Puneeta Tandon, Finlay A McAlister, Ross T Tsuyuki, et al.
Journal of the American Heart Association
|
July 25, 2022
Trends in Uptake and Adherence to Oral Anticoagulation for Patients With Incident Atrial Fibrillation at High Stroke Risk Across Health Care Settings
Haran Yogasundaram, Douglas C Dover, Nathaniel M Hawkins, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
January 22, 2021
Concurrent use of P-glycoprotein or Cytochrome 3A4 drugs and non-vitamin K antagonist oral anticoagulants in non-valvular atrial fibrillation
Roopinder K Sandhu, Sunjidatul Islam, Douglas C Dover, et al.
The American Journal of Cardiology
|
March 7, 2006
Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria
Mustafa Toma, Finlay A McAlister, Justin Ezekowitz, et al.
Journal of Clinical Medicine
|
July 29, 2025
Evaluating the Risk of Hypophosphatemia with Ferric Carboxymaltose and the Recommended Approaches for Management: A Consensus Statement
Giuseppe Rosano, Justin Ezekowitz, Elizabeta Nemeth, et al.
BMC Cancer
|
July 29, 2011
Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI
Edith Pituskin, Mark Haykowsky, John R Mackey, et al.
JAMA
|
June 15, 2007
Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review
Finlay A McAlister, Justin Ezekowitz, Nicola Hooton, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 109) with videos related to
Sort By:
Page
of 11
Journal of the American College of Cardiology
|
October 19, 2004
The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease
Justin Ezekowitz, Finlay A McAlister, Karin H Humphries, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
April 12, 2024
Impact of the method of calculating 30-day readmission rate after hospitalization for heart failure. Data from the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry
Samaneh Salimian, Sean A Virani, Thomas M Roston, et al.
Frontiers in Cardiovascular Medicine
|
November 8, 2019
Screening and Initiating Supportive Care in Patients With Heart Failure
Quynh Nguyen, Kaiming Wang, Anish Nikhanj, et al.
Archives of Internal Medicine
|
April 14, 2004
The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes
Puneeta Tandon, Finlay A McAlister, Ross T Tsuyuki, et al.
Journal of the American Heart Association
|
July 25, 2022
Trends in Uptake and Adherence to Oral Anticoagulation for Patients With Incident Atrial Fibrillation at High Stroke Risk Across Health Care Settings
Haran Yogasundaram, Douglas C Dover, Nathaniel M Hawkins, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
January 22, 2021
Concurrent use of P-glycoprotein or Cytochrome 3A4 drugs and non-vitamin K antagonist oral anticoagulants in non-valvular atrial fibrillation
Roopinder K Sandhu, Sunjidatul Islam, Douglas C Dover, et al.
The American Journal of Cardiology
|
March 7, 2006
Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria
Mustafa Toma, Finlay A McAlister, Justin Ezekowitz, et al.
Journal of Clinical Medicine
|
July 29, 2025
Evaluating the Risk of Hypophosphatemia with Ferric Carboxymaltose and the Recommended Approaches for Management: A Consensus Statement
Giuseppe Rosano, Justin Ezekowitz, Elizabeta Nemeth, et al.
BMC Cancer
|
July 29, 2011
Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI
Edith Pituskin, Mark Haykowsky, John R Mackey, et al.
JAMA
|
June 15, 2007
Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review
Finlay A McAlister, Justin Ezekowitz, Nicola Hooton, et al.
Page
of 11